Published in Eur J Pharm Biopharm on June 16, 2007
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Nanoparticles and their applications in cell and molecular biology. Integr Biol (Camb) (2014) 1.02
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl (2012) 1.00
Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci (2011) 0.97
Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues. Mol Ther (2011) 0.94
In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mater Med (2010) 0.94
Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Mol Pharm (2008) 0.92
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. Adv Drug Deliv Rev (2015) 0.86
Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res (2010) 0.85
Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) [corrected]. Eur J Pharm Biopharm (2008) 0.85
Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells. Int J Nanomedicine (2012) 0.84
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development. Cancer Nanotechnol (2012) 0.84
Nanotechnology for energy-based cancer therapies. Am J Cancer Res (2011) 0.81
Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier. Int J Nanomedicine (2012) 0.80
Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Adv Drug Deliv Rev (2016) 0.78
In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles. J Biol Inorg Chem (2015) 0.77
Rafts, Nanoparticles and Neural Disease. Nanomaterials (Basel) (2012) 0.75
Preparation and characterization of vinculin-targeted polymer-lipid nanoparticle as intracellular delivery vehicle. Int J Nanomedicine (2012) 0.75
Self-assembly of polyphosphazene immunoadjuvant with poly(ethylene oxide) enables advanced nanoscale delivery modalities and regulated pH-dependent cellular membrane activity. Heliyon (2016) 0.75
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 4.69
An activating immunoreceptor complex formed by NKG2D and DAP10. Science (1999) 4.56
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 4.40
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet (1997) 3.08
Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem (1985) 3.04
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol (1999) 2.57
The risks of blood transfusion: the relative influence of acquired immunodeficiency syndrome and non-A, non-B hepatitis. Am J Med (1992) 2.12
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther (1999) 1.96
Autoradiographic study of mannan incorporation into the growing cell walls of Saccharomyces cerevisiae. J Bacteriol (1974) 1.94
A new rapid slide test for infectious mononucleosis. JAMA (1965) 1.82
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry (2007) 1.80
Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol (1999) 1.76
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Dense growth of aerobic bacteria in a bench-scale fermentor. Biotechnol Bioeng (1976) 1.62
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. Clin Cancer Res (2001) 1.62
Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol (1999) 1.55
Endoscopic evaluation of exercise-induced pulmonary hemorrhage and chronic obstructive pulmonary disease in association with poor performance in racing Standardbreds. J Am Vet Med Assoc (1990) 1.51
Secretion of cell-wall glycoproteins by yeast protoplasts. Effect of 2-deoxy-D-glucose and cycloheximide. Biochem J (1970) 1.48
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48
SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli. Mol Gen Genet (1995) 1.45
Arterial hypoxemia following the administration of sublingual nitroglycerin. Am Heart J (1978) 1.44
Effect of surgical repair on the neurologic function in infants with lipomeningocele. Pediatr Neurosurg (1993) 1.40
Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway. Eur J Biochem (1985) 1.39
Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem (1986) 1.31
Extracellular beta-glucanases of the yeast, Saccharomyces cerevisiae. Biochim Biophys Acta (1973) 1.31
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25
Metabolism of 2-deoxy-D glucose by Baker's yeast. IV. Incorporation of 2-deoxy-D-glucose into cell wall mannan. Biochim Biophys Acta (1972) 1.24
High mobility, low voltage operating C(60) based n-type organic field effect transistors. Synth Met (2011) 1.21
Xylan-degrading activity in yeasts: growth on xylose, xylan and hemicelluloses. Folia Microbiol (Praha) (1978) 1.20
Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity (1999) 1.19
Mechanism of 2-deoxy-D-glucose inhibition of cell-wall polysaccharide and glycoprotein biosyntheses in Saccharomyces cerevisiae. Eur J Biochem (1975) 1.18
Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting. Eur J Pharm Biopharm (2007) 1.18
Commissioning of a micro multi-leaf collimator and planning system for stereotactic radiosurgery. Radiother Oncol (1999) 1.18
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood (1996) 1.17
Effect of 2-deoxyglucose on cell wall formation in Saccharomyces cerevisiae and its relation to cell growth inhibition. J Bacteriol (1971) 1.13
Maximal exponential growth rate and yield of E. coli obtainable in a bench-scale fermentor. Biotechnol Bioeng (1974) 1.13
A single origin of phenylketonuria in Yemenite Jews. Nature (1990) 1.11
The oxidation of fatty acids by a particulate fraction from desert-locust (Schistocerca gregaria) thorax tissues. Biochem J (1960) 1.10
In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability. Vaccine (1995) 1.10
Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med (1996) 1.08
Progressive liver calcifications in neonatal coxsackievirus infection. Pediatr Radiol (2000) 1.07
Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat Immunol (2001) 1.06
RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. J Immunol (1997) 1.06
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenomics J (2001) 1.05
The effect of a short message service maintenance treatment on body mass index and psychological well-being in overweight and obese children: a randomized controlled trial. Pediatr Obes (2012) 1.04
Sibling vesicoureteral reflux in multiple gestation births. Pediatrics (2000) 1.04
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells. Clin Biochem (2001) 1.03
Vesicoureteral reflux in asymptomatic siblings of patients with known reflux: radionuclide cystography. Pediatrics (1987) 1.03
Site of mannan synthesis in yeast. An autoradiographic study. Arch Microbiol (1974) 1.02
Inhibitory effect of 2-deoxy-d-glucose on the formation of the cell wall in yeast protoplasts. J Bacteriol (1969) 1.01
The formation of guanosine diphosphate-2-deoxy-D-glucose in yeast. Biochim Biophys Acta (1968) 1.01
Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? J Urol (2001) 1.00
The physician assistant: Shifting the Paradigm of European medical practice? HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.00
Lysis of Saccharomyces cerevisiae with 2-deoxy-2-fluoro-D-glucose, an inhibitor of the cell wall glucan synthesis. J Bacteriol (1973) 0.99
Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin Pharmacol Ther (1999) 0.98
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis. Eur J Cancer (2012) 0.97
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transplant (2007) 0.96
Interaction of concanavalin A with external mannan-proteins of Saccharomyces cerevisiae. Glycoprotein nature of beta-glucanases. Eur J Biochem (1976) 0.96
Vulnerability of OFDR-based distributed sensors to high γ-ray doses. Opt Express (2015) 0.96
Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur J Cancer (1995) 0.96
Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen. Acta Cytol (1992) 0.95
[Registries as a method to promote quality improvement--an investigation based on the example of assisted reproduction]. Gesundheitswesen (2003) 0.95
Hypothermic bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta. Ann Thorac Surg (1995) 0.94
Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli. J Bacteriol (1996) 0.94
NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer (2011) 0.94
TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta (2005) 0.94
Apigenin--strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo. Phytomedicine (2002) 0.93
Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res (1996) 0.93
Experimental evidence for a motivational origin of cognitive impairment in major depression. Psychol Med (2007) 0.93
[The structurizing effect of minimum quantitative requirements for inpatient care]. Gesundheitswesen (2005) 0.93
Quantification of the antipsychotics flupentixol and haloperidol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl (1998) 0.93
Intracerebral inoculation of suckling mice with Hantaan virus. Lancet (1982) 0.93
HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions. Cancer Immunol Immunother (1996) 0.92
Fallout from nuclear tests: health effects in Kazakhstan. Radiat Environ Biophys (2002) 0.92
Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. Pharmacogenetics (1999) 0.92
Experience and technique for the endovascular management of iatrogenic subclavian artery injury. Ann Vasc Surg (2009) 0.91
Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins. J Immunol Methods (2001) 0.91
Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet (2011) 0.91
Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism. Clin Pharmacol Ther (1999) 0.90
Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain. J Control Release (2007) 0.90
The modular cellulase CelZ of the thermophilic bacterium Clostridium stercorarium contains a thermostabilizing domain. FEMS Microbiol Lett (1998) 0.90
Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A (2009) 0.90
Volume and pH of gastric juice in obese patients. Anesthesiology (1975) 0.90
The influence of the peptide chain length on the activity of peptidyl-tRNA hydrolase from E. coli. Nucleic Acids Res (1975) 0.90
Bioactivation of titanium surfaces using coatings of TiO(2) nanotubes rapidly pre-loaded with synthetic hydroxyapatite. Acta Biomater (2009) 0.90
Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm. Interface Focus (2011) 0.89
Production of pro- and anti-inflammatory cytokines of human placental trophoblasts in response to pathogenic bacteria. J Soc Gynecol Investig (2001) 0.89
NAT2*12A (803A-->G) codes for rapid arylamine n-acetylation in humans. Pharmacogenetics (1996) 0.89
Ferroelectric polarization in nanocrystalline hydroxyapatite thin films on silicon. Sci Rep (2013) 0.89
TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta (2000) 0.88
Survival of allografts after hepatic portal venous administration of specific transplantation antigen. Ann Surg (1969) 0.88
Gracilis muscle transposition in the treatment of faecal incontinence. Int J Colorectal Dis (1996) 0.87
A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15. Pharmacogenetics (1996) 0.87
[Continuous individual support of smoking cessation in socially deprived young adults via mobile phones--results of a pilot study]. Gesundheitswesen (2008) 0.87
Effect of ammonia on the anaerobic degradation of protein by a mesophilic and thermophilic biowaste population. Appl Microbiol Biotechnol (1998) 0.87